AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2022
Jan 4, 2022
32044_dirs_2022-01-04_3119f987-1acd-41bf-ab6c-b65770995159.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-01-02
Reporting Person: Sabzevari Helen (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-02 | Common Stock | M | 9765 | — | Acquired | 727291 | Direct |
| 2022-01-03 | Common Stock | S | 3848 | $3.6701 | Disposed | 723443 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-02 | Restricted Stock Units | $ | M | 9765 | Disposed | Common Stock (9765) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3: The RSUs were granted on January 2, 2018 and have vested in full.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23